The Utility of Serial Lipid Measurements as a Potential Predictor of Sepsis Outcome: A Prospective Observational Study in a Tertiary Care Hospital

1. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8(4):222–6. Linde-ZwirbleWT AngusDC Severe sepsis epidemiology: sampling, selection, and society Crit Care 2004 8 4 222 6 Search in Google Scholar

2. Chatterjee S, Bhattacharya M, Todi SK. Epidemiology of Adult-population Sepsis in India: A Single Center 5 Year Experience. Indian J Crit Care Med. 2017;21(9):573–7. ChatterjeeS BhattacharyaM TodiSK Epidemiology of Adult-population Sepsis in India: A Single Center 5 Year Experience Indian J Crit Care Med 2017 21 9 573 7 Search in Google Scholar

3. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10. SingerM DeutschmanCS SeymourCW Shankar-HariM The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016 315 8 801 10 Search in Google Scholar

4. Gaddam BK, Narayanan M. Study of serum HDL-cholesterol levels in sepsis patients and its prognostic significance. Int J Adv Med. 2019;6(2):312–17. GaddamBK NarayananM Study of serum HDL-cholesterol levels in sepsis patients and its prognostic significance Int J Adv Med 2019 6 2 312 17 Search in Google Scholar

5. Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly. 2005;135(31–32):451–60. Christ-CrainM MullerB Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005 135 31–32 451 60 Search in Google Scholar

6. Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol. 2020; 11:599853. CioccariL LuethiN MasoodiM Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine Front Immunol 2020 11 599853 Search in Google Scholar

7. van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31(5):1359–66. van LeeuwenHJ HeeziusEC DallingaGM Lipoprotein metabolism in patients with severe sepsis Crit Care Med 2003 31 5 1359 66 Search in Google Scholar

8. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase is increased in vivo by inflammation in humans. Circulation. 2008;117(5):678–85. BadellinoKO WolfeML ReillyMP RaderDJ Endothelial lipase is increased in vivo by inflammation in humans Circulation 2008 117 5 678 85 Search in Google Scholar

9. Tanaka S, Couret D, Tran-Dinh A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134. TanakaS CouretD Tran-DinhA High-density lipoproteins during sepsis: from bench to bedside Crit Care 2020 24 1 134 Search in Google Scholar

10. Rapsang AG, Shyam DC. Scoring systems in the intensive care unit: A compendium. Indian J Crit Care Med. 2014;18(4):220–8. RapsangAG ShyamDC Scoring systems in the intensive care unit: A compendium Indian J Crit Care Med 2014 18 4 220 8 Search in Google Scholar

11. Badrinath K, Shekhar M, Sreelakshmi M, et al. Comparison of Various Severity Assessment Scoring Systems in Patients with Sepsis in a Tertiary Care Teaching Hospital. Indian J Crit Care Med. 2018;22(12):842–845. BadrinathK ShekharM SreelakshmiM Comparison of Various Severity Assessment Scoring Systems in Patients with Sepsis in a Tertiary Care Teaching Hospital Indian J Crit Care Med 2018 22 12 842 845 Search in Google Scholar

12. APACHE II – ClinCalc. http:// ClinCalc.com>ICU Mortality>APACHE II. APACHE II – ClinCalc http:// ClinCalc.com>ICU Mortality>APACHE II. Search in Google Scholar

13. Rudd KE, Johnson SC, Agesa KM, et al. D. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200–11. RuddKE JohnsonSC AgesaKM D. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study Lancet 2020 395 200 11 Search in Google Scholar

14. Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ 2016;353: i1585. GottsJE MatthayMA Sepsis: pathophysiology and clinical management BMJ 2016 353 i1585 Search in Google Scholar

15. https://www.who.int/news-room/fact-sheets/detail/sepsis. https://www.who.int/news-room/fact-sheets/detail/sepsis. Search in Google Scholar

16. Napolitano LM. Sepsis 2018: Definitions and Guideline Changes. Surg Infect (Larchmt). 2018;19(2):117–25. NapolitanoLM Sepsis 2018: Definitions and Guideline Changes Surg Infect (Larchmt) 2018 19 2 117 25 Search in Google Scholar

17. Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017; 5:51. VijayanAL Vanimaya RavindranS Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy J Intensive Care 2017 5 51 Search in Google Scholar

18. Dahaba AA, Hagara B, Fall A, et al. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006;97(4):503–8. DahabaAA HagaraB FallA Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis Br J Anaesth 2006 97 4 503 8 Search in Google Scholar

19. Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect. 2002;8(2):93–100. BrunkhorstFM Al-NawasB KrummenauerF ForyckiZF ShahPM Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia Clin Microbiol Infect 2002 8 2 93 100 Search in Google Scholar

20. Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018;13(11): e0206527. YunusI FasihA WangY The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics PLoS One 2018 13 11 e0206527 Search in Google Scholar

21. Rashwan D, Al Kassem Rashwan SA, Hassan WF, Sayem DM. Prognostic Value of Serum Cholesterol and Triglyceride in Septic and Non-septic Patients: Randomized Double-blinded Study. J Intensive & Crit Care. 2019;1:1–7. RashwanD Al Kassem RashwanSA HassanWF SayemDM Prognostic Value of Serum Cholesterol and Triglyceride in Septic and Non-septic Patients: Randomized Double-blinded Study J Intensive & Crit Care 2019 1 1 7 Search in Google Scholar

22. Sunayana P, Renymol B, Ambili N. Fasting Lipid Profile and Disease Severity in Sepsis Patients. Journal of Clinical and Diagnostic Research. 2017;11(11): OC10–OC12. SunayanaP RenymolB AmbiliN Fasting Lipid Profile and Disease Severity in Sepsis Patients Journal of Clinical and Diagnostic Research 2017 11 11 OC10 OC12 Search in Google Scholar

23. Cetinkaya A, Erden A, Avci D, et al. Is hypertriglyceridemia a prognostic factor in sepsis? Ther Clin Risk Manag. 2014; 10:147–50. CetinkayaA ErdenA AvciD Is hypertriglyceridemia a prognostic factor in sepsis? Ther Clin Risk Manag 2014 10 147 50 Search in Google Scholar

24. Sharma NK, Ferreira BL, Tashima AK, et al. Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis. Clin Proteomics. 2019; 16:29. SharmaNK FerreiraBL TashimaAK Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis Clin Proteomics 2019 16 29 Search in Google Scholar

25. Morin EE, Guo L, Schwendeman A, Li XA. HDL in sepsis - risk factor and therapeutic approach. Front Pharmacol. 2015;6:244. MorinEE GuoL SchwendemanA LiXA HDL in sepsis - risk factor and therapeutic approach Front Pharmacol 2015 6 244 Search in Google Scholar

26. Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688–93. ChienJY JerngJS YuCJ YangPC Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis Crit Care Med 2005 33 8 1688 93 Search in Google Scholar

27. Maile MD, Sigakis MJ, Stringer KA, Jewell ES, Engoren MC. Impact of the pre-illness lipid profile on sepsis mortality. J Crit Care. 2020;57:197–202. MaileMD SigakisMJ StringerKA JewellES EngorenMC Impact of the pre-illness lipid profile on sepsis mortality J Crit Care 2020 57 197 202 Search in Google Scholar

28. Chang L, Chen X, Lian C. The association between the non-HDL-cholesterol to HDL-cholesterol ratio and 28-day mortality in sepsis patients: a cohort study. Sci Rep. 2022;12(1):3476. ChangL ChenX LianC The association between the non-HDL-cholesterol to HDL-cholesterol ratio and 28-day mortality in sepsis patients: a cohort study Sci Rep 2022 12 1 3476 Search in Google Scholar